» Articles » PMID: 22981247

The Withholding of Test Results As a Means of Assessing the Effectiveness of Treatment in Test-positive Persons

Overview
Publisher Elsevier
Specialty Public Health
Date 2012 Sep 18
PMID 22981247
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, a number of studies have achieved randomization of patients to alternative management strategies by blinding some patients (and their providers of medical care) to the results of tests that guide such strategies. Although this research approach has the potential to be a powerful means of measuring treatment effectiveness, the interpretation of the results may not be straightforward if the treatment received by test-positive persons is variable or not well documented, or if the analysis is not restricted to outcomes in test-positive persons. Studies in which the test results are withheld at random may face ethical issues that, to date, have received little discussion.

Citing Articles

Testing stored control-arm specimens could dramatically increase statistical power yet reduce costs in cancer screening trials.

Katki H J Natl Cancer Inst. 2024; 117(3):393-395.

PMID: 39699223 PMC: 11884858. DOI: 10.1093/jnci/djae293.


Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.

Katki H, Prorok P, Castle P, Minasian L, Pinsky P J Natl Cancer Inst. 2024; 116(8):1280-1287.

PMID: 38603624 PMC: 11308171. DOI: 10.1093/jnci/djae083.


Randomized trials of multicancer screening tests: augmenting their ability to identify a genuine mortality benefit.

Weiss N J Natl Cancer Inst. 2024; 116(7):1005-1007.

PMID: 38449292 PMC: 11223825. DOI: 10.1093/jnci/djae059.